0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query la merie publishing competitor analysis kallikrein inhibitors 2017.Your search for "" gave back 1504438 results.
Cytokine-engineering as a measure to reduce dose-limiting toxicities of immunocytokines The development of recombinant cytokines, or mainly antibody-...
Catalog:
La Merie Publishing
January 2014
Price: USD 334.13
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the...
Catalog:
La Merie Publishing
January 2015
Price: USD 249.00
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor...
Catalog:
La Merie Publishing
November 2014
Price: USD 444.00
Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid hormone 1 receptor (PTH1R) functions as a receptor for...
Catalog:
La Merie Publishing
October 2013
Price: USD 265.00
Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
EGF-R Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about EGF-R Antibodies –Biosimilars and Biosuperiors...
Catalog:
La Merie Publishing
March 2014
Price: USD 344.00
The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
Catalog:
La Merie Publishing
February 2014
Price: USD 413.00
According to our Publisher latest study, the global Mitogen-Activated Protein Kinase Inhibitor market size was valued at USD million in 2022 and is...
Catalog:
GIR
February 2023
Price: USD 3,480.00
VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors The present Competitive Intelligence Report about VEGF Antibodies –...
Catalog:
La Merie Publishing
February 2014
Price: USD 401.00
Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases This Competitive Intelligence report about Bispecific...
Catalog:
La Merie Publishing
June 2016
Price: USD 560.00
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the...
Catalog:
La Merie Publishing
March 2015
Price: USD 346.00
TNF Antibodies –Biosimilars and Biosuperiors The present Competitive Intelligence Report about TNF Antibodies –Biosimilars and Biosuperiors provides...
Catalog:
La Merie Publishing
March 2014
Price: USD 551.00
The global Hereditary Angioedema Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
Catalog:
La Merie Publishing
November 2016
Price: USD 784.00
